Sulfuric Acid

Sulfuric Acid

SCHEMBL7540439

COC(=O)Nc1ccc(C(CCNC(Oc2ccccc2)C(C)O)c2ccc(NC(=O)OC)cc2)cc1.O=S(=O)(O)O

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.44
HPGD P15428 1/20 0.44
CASR P41180 5/20 0.44
ALDH1A1 P00352 4/20 0.43
LMNA P02545 4/20 0.43
TP53 P04637 2/20 0.43
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
GAA P10253 1/20 0.43
RAB9A P51151 3/20 0.40
NPC1 O15118 2/20 0.40
MAPT P10636 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
ALOX15 P16050 1/20 0.38
TSHR P16473 1/20 0.38
CYP2C19 P33261 1/20 0.38
NR3C1 P04150 1/20 0.38
PKM P14618 1/20 0.38
CNR1 P21554 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7768377 0.96 SMN1; SMN2 (0.48) SMN1; SMN2HPGDCASRALDH1A1LMNA
SCHEMBL7536032 0.87 KMT2A (0.43) SMN1; SMN2HPGDCASRALDH1A1LMNA
SCHEMBL7613185 0.86 RAB9A (0.53) SMN1; SMN2HPGDCASRALDH1A1LMNA
SCHEMBL7612545 0.86 CASR (0.46) CASRALDH1A1LMNATP53KMT2A
SCHEMBL7610407 0.85 GLA (0.48) SMN1; SMN2CASRALDH1A1LMNATP53
SCHEMBL7595294 0.84 CASR (0.50) CASRALDH1A1LMNAKMT2AMEN1
SCHEMBL7612159 0.84 RAB9A (0.46) SMN1; SMN2HPGDCASRALDH1A1LMNA
SCHEMBL7610781 0.80 ADRB2 (0.40) SMN1; SMN2HPGDCASRRAB9ANPC1
SCHEMBL7605257 0.79 KMT2A (0.41) SMN1; SMN2CASRALDH1A1LMNATP53
SCHEMBL7610419 0.78 KMT2A (0.54) SMN1; SMN2CASRALDH1A1LMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1257528-A1 AMINOALCOHOL DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-11-20 EP disclosed
WO-2002036552-A1 AMINOALCOHOL DERIVATIVES AND THEIR USE AS BETA 3 ADRENERGIC AGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-05-10 WO disclosed
WO-2001060786-A1 AMINOALCOHOL DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-08-23 WO disclosed